Clearance for First-Ever Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment Pivotal Milestone Unlocks ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced it ...

The company notes the synthesized output is not intended to replace a standard 12-lead ECG. HeartBeam also plans to advance development of an on-demand 12-lead ECG extended wear monitor and build ...

Twelve-lead ECGs, although standard in hospitals, can be bulky and impractical for home use. On the other hand, Apple Watch’s ECG app is easy to use, but it is limited in what it can detect because it ...

ECG diagnostics software platform AccurKardia and cardiac medical technology company HeartBeam are joining forces to make AccurKardia's ECG analysis software available on HeartBeam's devices.

Sinus bradycardia, or a slow heart rate, can be a sign of cardiovascular health in healthy young adults and endurance athletes. It can also be a sign of an underlying condition requiring medical ...

The correct diagnosis is sinus bradycardia with a sinus pause due to sinus node arrest (Figure 2). Figure 2. Courtesy of Philip J. Podrid, MD. The rhythm is regular except for one long RR interval or ...

Austin, Texas, United States, January 5th, 2026, FinanceWire HeartBeam (NASDAQ: BEAT), a medical technology company focused ...